<DOC>
	<DOCNO>NCT01398748</DOCNO>
	<brief_summary>Excessive free radical formation depletion brain 's primary antioxidant , glutathione , establish component Parkinson 's disease ( PD ) pathophysiology . While rationale therapeutic use reduce glutathione ( GSH ) PD , even preliminary evidence suggest use GSH lead symptomatic improvement , obstacle surround currently employ delivery method hinder clinical utility therapy . Intranasal GSH , ( ) GSH , novel method delivery popular CAM therapy patient PD , bypass obstacle associate delivery method . It use clinical practice since 2005 . The aim study evaluate safety , tolerability , preliminary absorption data ( ) GSH volunteer PD Phase I single ascend dose escalation study .</brief_summary>
	<brief_title>Intranasal Glutathione Parkinson 's Disease</brief_title>
	<detailed_description>Individuals randomize one three treatment ( 100 mg GSH/ ml , 200 mg GSH/ ml , placebo ) arm double-blind fashion . All study medication administer 1 ml three time daily three month , one-month wash .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1 . Diagnosis Parkinson 's Disease make neurologist within previous 10 year 2 . Modified Hoehn Yahr Stage &lt; 3 3 . Age &gt; 20 4 . Subjects must able attend study visit screen , baseline , week 4 , 8 , 12 , 16 5 . Subjects must able demonstrate selfadministration study medication active caregiver administer daily . 6 . Dose frequency pharmaceutical medication must stable one month prior enrollment . 7 . Diet , exercise supplementation must keep constant throughout participation study 8 . Ability read speak English 1 . Dementia evidence Montreal Cognitive Assessment ( MoCA ) &lt; 24 2 . Diseases feature common Parkinson 's Disease ( eg . essential tremor , multiple system atrophy , progressive supranuclear palsy ) 3 . Epilepsy 4 . History stroke , CVA 5 . Elevated level ALT , AST , BUN creatinine 6 . Chronic sinusitis define SNOT20 score &gt; 1.0 item 110 . 7 . Presence serious illness 8 . History brain surgery 9 . History structural brain damage 10 . History intranasal telangiectasia 11 . Supplementation glutathione agent show increase glutathione permit require 90 day washout period . 12 . Pregnant risk become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Neuroprotection</keyword>
	<keyword>Glutathione</keyword>
	<keyword>Intranasal</keyword>
</DOC>